Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,704 public trials 1,044 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung Cancer

NCT00805194

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • LKH-Univ. Hospital Graz Graz, Austria
  • KH St. Vinzenz, Zams, Int. Abtlg. Kufstein, Austria
  • AKH d. Stadt Linz, Pulmologie Linz, Austria
  • Bobruisk Inter-distict Babruysk, Belarus
View all 210 locations
View Trial Details
Completed

A Study of the Safety, Tolerability, and Effects of Cobimetinib and GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors

NCT02457793

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +27 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

Nivolumab in the Real World: Analysis of the Expanded Use in Spanish Patient

NCT03132493

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Hospital Virgen de los Lirios Alcoy, Alicante, Spain
  • Hospital de Elche Elche, Alicante, Spain
  • Hospital Universitario de Vinalopó Elche, Alicante, Spain
  • Hospital General Universitario de Elda Elda, Alicante, Spain
View all 61 locations
View Trial Details
Completed

Disease Characteristics, Treatment Patterns and Clinical Outcomes in Patients With Newly Diagnosed Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) in China

NCT02458651

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Cancer Hospital Chinese Academy of Medical Sciences. Beijing, China
  • the First Hospital of Jilin University Changchun, China
  • Sichuan Provincial Cancer Hospital Chengdu, China
  • Third Affiliated Hospital of Third Military Medical University Chongqing, China
View Trial Details
Completed

A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment

NCT01801111

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • St. Jude Heritage Healthcare Fullerton, California, United States
  • UC Irvine Medical Center Orange, California, United States
  • Sharp Memorial Hospital San Diego, California, United States
View all 84 locations
View Trial Details
Completed

Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility Study

NCT01836692

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Belfast Health & Social Care NHS Trust - Northern Ireland Cancer Centre Belfast, United Kingdom
  • Cambridge University Hospitals NHS Foundation Trust - Addenbrookes Hospital Cambridge, United Kingdom
  • Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
  • Leeds Teaching Hospitals NHS Trust - St James's University Hospital Leeds, United Kingdom
View Trial Details

Related conditions